Dr. Sauter is Director of the Blood and Marrow Transplant program at Cleveland Clinic. Currently, he is a member of the Case Comprehensive Cancer Center as part of the Immune Oncology Research Program and is a member of the National Center for Regenerative Medicine (NCRM). Additionally, he is a member of the Cleveland Clinic Global Center for Immunotherapy (CITI). His research has focused on improving the outcome of patients with relapsed and refractory (rel/ref) non-Hodgkin lymphoma (NHL) with hematopoietic cell transplantation (HCT) and cellular therapy. He previously served as the Co-Chair of the Lymphoma Working Committee in the Center for International Blood and Marrow Transplantation Research (CIBMTR) and as the Chairperson of the Tri-State Transplant Consortium (TSTC).